Showing results (141-150 of 281) with videos related to

Sort By:
Pageof 29
Cancer Genetics and Cytogenetics|August 26, 2000
Characterization of the topoisomerase I locus in human colorectal cancerA Boonsong, S Marsh, P H Rooney, et al.
Annals of Neurology|December 1, 1994
High-dose dextromethorphan in amyotrophic lateral sclerosis: phase I safety and pharmacokinetic studiesD Hollander, J Pradas, R Kaplan, et al.
Clinical Pharmacology and Therapeutics|July 2, 2010
Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivityS-H Chen, D Pei, W Yang, et al.
Annals of Internal Medicine|April 15, 1997
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intoleranceC R Yates, E Y Krynetski, T Loennechen, et al.
Mutation Research|September 3, 1998
A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprtC L Chen, M H Woo, G A Neale, et al.
Pharmacogenetics|August 1, 1996
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanismsE Y Krynetski, H L Tai, C R Yates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group StudyC A Hurwitz, M V Relling, S D Weitman, et al.
Leukemia|December 13, 2005
Genome-wide approach to identify risk factors for therapy-related myeloid leukemiaA Bogni, C Cheng, W Liu, et al.
British Journal of Cancer|August 26, 2004
RNA profiling of cyclooxygenases 1 and 2 in colorectal cancerR D Church, J Yu, J W Fleshman, et al.
The Journal of Pathology|March 2, 2006
Expression of drug pathway proteins is independent of tumour typeW Zhang, W D Shannon, J Duncan, et al.
Pageof 29